Abstract
Background: Hereditary angioedema is classified as a primary immunodeficiency of the complement system because it is characterized by the absence of C1 esterase inhibitor (C1-INH) and by the periodic edema of any region of the body that involves soft tissue.
Objective: To characterize the adult patients with a confirmed diagnosis of hereditary angioedema who have been treated in the Clinical Allergology Department of Hospital México de la Caja Costarricense del Seguro Social.
Methods: The study was retrospective and observational. The information was obtained from the clinical records of the patients with a confirmed diagnosis of hereditary angioedema that were being controlled in the Allergology Department of the “Hospital México de la Caja Costarricense del Seguro Social”.
Results: A total of 14 patients; seven men and seven women, were identified. The average was of 36.6 years of age. The most frequent clinical manifestations were peripheral edema and abdominal pain. Only three patients presented laryngeal edema at some point in their evolution. 12 cases corresponded to hereditary angioedema type I.
Conclusion: The clinical characteristics of all the documented cases corresponded to those described for this pathology, although only a few patients had a history of severe manifestations.
References
Bousfiha A, Jeddane L, Picard C, Ailal F, Gaspar HB, Chatila T, et al. The 2017 IUIS Phenotypic Classification for Primary Immunodeficiencies. J Clin Immunol. 2018;38(1):129-143. DOI: 10.1007/s10875-017-0465-8
Levi M, Cohn DM. The role of complement in hereditary angioedema. Transfus Med Rev. 2019;33(4):243-247. DOI: 10.1016/j.tmrv.2019.08.002
Kaplan AP, Joseph K. Complement, kinins, and hereditary angioedema: mechanisms of plasma instability when C1 inhibitor is absent. Clin Rev Allergy Immunol. 2016;51(2):207-215. DOI: 10.1007/s12016-016-8555-6
Agostoni A, Cicardi M. Hereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patients. Medicine (Baltimore). 1992;71(4):206-215. DOI: 10.1097/00005792-199207000-00003
Germenis AE, Speletas M. Genetics of hereditary angioedema revisited. Clin Rev Allergy Immunol. 2016;51(2):170-182. DOI: 10.1007/s12016-016-8543-x
López-Lera A, Garrido S, Roche O, López-Trascasa M. SERPING1 mutations in 59 families with hereditary angioedema. Mol Immunol. 2011;49(1-2):18-27. DOI: 10.1016/j.molimm.2011.07.010
Nussberger J, Cugno M, Amstutz C, Cicardi M, Pellacani A, Agosoni A. Plasma bradykinin in angio-oedema. Lancet. 1998;351(9117):1693-1697. DOI: 10.1016/S0140-6736(97)09137-X
Kaplan AP, Joseph K, Silverberg M. Pathways for bradykinin formation and inflammatory disease. J Allergy Clin Immunol. 2002;109(2):195-209. DOI: 10.1067/mai.2002.121316
Longhurst HJ, Farkas H, Craig T, Bethune C, Bork K, Boysen H, et al. HAE international home therapy consensus document. Allergy Asthma Clin Immunol. 2010;6(1):22. DOI: 10.1186/1710-1492-6-22
Caballero T, Baeza ML, Cabañas R, Campos A, Cimbollek S, Guilarte M, et al. Consensus statement on the diagnosis, management, and treatment of angioedema mediated by bradykinin. Part I. Classification, epidemiology, pathophysiology, genetics, clinical symptoms, and diagnosis. J Investig Allergol Clin Immunol. 2011;21(5):333-347. Disponible en: http://alergialafe.org/descargas/AEparte22012.pdf
Cicardi M, Aberer W, Banerji A, Bas M, Bork K, Caballero T, et al. Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group. Allergy. 2014;69(5):602-616. DOI: 10.1111/all.12380
Zuraw BL, Christiansen SC. Pathogenesis and laboratory diagnosis of hereditary angioedema. Allergy Asthma Proc. 2009;30(5):487-492. DOI: 10.2500/aap.2009.30.3277
Maurer M, Magerl M, Ansotegui, I, Aygören-Pürsün E, Betschel S, Bork K, et al. The international WAO/EAACI guideline for the management of hereditary angioedema-the 2017 revision and update. Allergy. 2018;73(8):1575-1596. DOI: 10.1111/all.13384
Bork K, Aygören-Pürsün E, Bas M, Biedermann T, Greve J, Hartmann K, et al. Guideline: hereditary angioedema due to C1 inhibitor deficiency. Allergo J Int. 2019;28(1):16-29. Disponible en: https://link.springer.com/article/10.1007/s40629-018-0088-5
Zeerleder S. C1-inhibitor: more than a serine protease inhibitor. Semin Thromb Hemost. 2011;37(4):362-374. DOI: 10.1055/s-0031-1276585
Gallais-Sérézal I, Bouillet L, Dhôte R, Gayet S, Martin L, Mekinian A, et al. Hereditary angioedema and lupus: a French retrospective study and literature review. Autoimmun Rev. 2015;14(6):564-568. DOI: 10.1016/j.autrev.2015.02.001
Cook HT, Botto M. Mechanisms of disease: the complement system and the pathogenesis of systemic lupus erythematosus. Nat Clin Pract Rheumatol. 2006;2(6):330-337. DOI: 10.1038/ncprheum0191
Bond WR, Herrod HG, Duberstein LE. Hereditary angioedema: association with IgA deficiency and otolaryngologic disorders. Laryngoscope. 1981;91(3):416-421. DOI: 10.1288/00005537-198103000-00012
Eskander A, de Almeida JR, Irish JC. Acute upper airway obstruction. N Engl J Med. 2019;381(20):1940-1949. DOI: 10.1056/NEJMra1811697
Bork K, Meng G, Staubach P, Hardt J. Hereditary angioedema: new findings concerning symptoms, affected organs, and course. Am J Med. 2006;119(3):267-274. DOI: 10.1016/j.amjmed.2005.09.064
Nzeako UC, Longhurst HJ. Many faces of angioedema: focus on the diagnosis and management of abdominal manifestations of hereditary angioedema. Eur J Gastroenterol Hepatol. 2012;24(4):353-361. DOI: 10.1097/MEG.0b013e3283517998
Ohsawa I, Nagamachi S, Suzuki H, Honda D, Sato N, Ohi H, et al. Leukocytosis and high hematocrit levels during abdominal attacks of hereditary angioedema. BMC Gastroenterol. 2013;13(1):123. DOI: 10.1186/1471-230X-13-123
Jalaj S, Scolapio JS. Gastrointestinal manifestations, diagnosis, and management of hereditary angioedema. J Clin Gastroenterol. 2013;47(10):817-823. DOI: 10.1097/MCG.0b013e31829e7edf
Koruth JS, Eckardt AJ, Levey JM. Hereditary angioedema involving the colon: endoscopic appearance and review of GI manifestations. Gastrointest Endosc. 2005;61(7):907-911. DOI: 10.1016/s0016-5107(05)00334-2
Gakhal MS, Marcotte GV. Hereditary angioedema: imaging manifestations and clinical management. Emerg Radiol. 2015;22(1):83-90. DOI: 10.1007/s10140-014-1242-0
Lumry WR. Overview of epidemiology, pathophysiology, and disease progression in hereditary angioedema. Am J Manag Care. 2013;19(7 Suppl):s103-s110. Disponible en: https://www.ajmc.com/journals/supplement/2013/ace010_13jun_hae_ce/ace010_13jun_lumry1_s103to10
Zuraw BL. Hereditary angioedema. N Engl J Med. 2008;359(10):1027-1036. DOI: 10.1056/NEJMcp0803977
Craig TJ, Levy RJ, Wasserman RL, Bewtra AK, Hurewitz D, Obtułowicz K, et al. Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks. J Allergy Clin Immunol. 2009;124(4):801-808. DOI: 10.1016/j.jaci.2009.07.017
Zuraw BL, Busse PJ, White M, Jacobs J, Lumry W, Baker J, et al. Nanofiltered C1 inhibitor concentrate for treatment of hereditary angioedema. N Engl J Med. 2010;363(6):513-522. DOI: 10.1056/NEJMoa0805538
Cicardi M, Banerji A, Bracho F, Malbrán A, Rosenkranz B, Riedl M, et al. Icatibant, a new Bradykinin-receptor antagonist, in hereditary angioedema. N Engl J Med. 2010;363(6):532-541. DOI: 10.1056/NEJMoa0906393
Pedrosa M, Phillips-Angles E, López-Lera A, López-Trascasa M, Caballero T. Complement study versus CINH gene testing for the diagnosis of type I hereditary angioedema in children. J Clin Immunol. 2016;36(1):16-18. DOI: 10.1007/s10875-015-0222-9
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright (c) 2020 Revista Alergia México